Morgan Stanley cuts Qifu Technology stock price target on rate pressure

Morgan Stanley cut Qifu Technology’s price target to $25 from $34 while keeping an Overweight rating, citing regulatory guidance that should keep pressure on lending rates, loan volume, and net take rate. The firm also reduced earnings forecasts, though it said the 11.3% dividend yield and potential capital returns may help support the stock. The company recently posted a Q4 2025 earnings miss, with EPS of 7.82 versus 9.17 expected and revenue of CNY 4.09 billion versus CNY 5.03 billion consensus.

Analysis

The key market signal is not the target cut itself, but the direction of travel: regulators are trying to compress system-wide lending spreads, which means the pain is less about one quarter’s earnings miss and more about a slower reset in industry ROE. For QFIN, that puts the stock in a classic value trap window where headline valuation can look cheap while the earnings base is still being mechanically revised lower over the next 2-3 reporting cycles.

The dividend is doing most of the work in the bull case, but that support is fragile if credit growth slows faster than expected or if buyback/capital-return flexibility is constrained by policy. In that scenario, yield becomes a valuation floor only if cash generation remains stable; if not, the market will start treating the payout as a signal of limited reinvestment opportunities rather than shareholder friendliness.

Second-order, the real winners are higher-quality consumer lenders and platform-based financials with better pricing power and lower reliance on net take-rate compression. The losers are peers still using growth-at-any-cost underwriting, because regulatory pressure on loan rates usually forces a race to the bottom in origination volumes before balance-sheet discipline reasserts itself. Over the next 1-2 months, any further guidance reset will likely matter more than reported historical EPS because the market is trading the forward margin architecture, not the past quarter.

The contrarian read is that the selloff may already reflect a lot of the regulatory overhang, especially with the stock at a deep discount and a double-digit yield. If management can show that loan volume stabilizes while credit quality remains contained, the stock can rerate sharply simply because expectations are now low enough that ‘less bad’ becomes a catalyst. The risk/reward is therefore asymmetric only for investors willing to tolerate policy-driven earnings volatility over a 6-12 month horizon.

Key Decisions for Investors

• Long QFIN only as a yield-plus-catalyst trade: build on weakness, but size small until the next guidance update confirms loan volume stabilization; upside is a 30-50% rerating if policy pressure proves manageable, downside is another 20-30% if earnings revisions continue.
• Sell covered calls against existing QFIN longs into any pre-earnings bounce to monetize elevated uncertainty; target 1-2 month maturities and strikes 10-15% above spot to preserve dividend carry while dampening drawdown.
• Pair trade: long a higher-quality consumer fintech lender versus short QFIN for 3-6 months to isolate regulatory margin compression risk while keeping broad sector exposure neutral; the short leg should outperform if take-rate pressure persists.
• Avoid adding to QFIN ahead of any fresh regulatory commentary or management guidance reset; the next catalyst window is the next earnings call, and the stock remains vulnerable to another 5-10% downgrade cascade on even modest miss/guide-down risk.
• If seeking optionality, use call spreads rather than outright stock for a 6-12 month rebound thesis; the asymmetric upside comes from multiple expansion, but the earnings path remains too policy-dependent for aggressive leverage.